Subiela J.D., González-Padilla D.A., Huguet J., Aumatell J., Rodríguez-Faba O., Krajewski W., Feliu A.H., Mínguez C., Plaza J.L., Artiles Medina A., Gajate P., Jiménez Cidre M.Á., Burgos Revilla J., Breda A., Palou J.. Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma. UROLOGY. 2023; 172DOI:10.1016/j.urology.2022.08.064. PMID:36436672. IF:2.100(Q2/5D).

Borràs J., Alonso-Tarrés C., Vives A., Palou J.. Neisseria meningitidis and the increase of oral sex. A case report. Revista Internacional de Andrologia. 2023; 21(1)DOI:10.1016/j.androl.2021.02.010. PMID:36307367. IF:0.800(Q4/10D).

Fontanet S., Huguet J., Gaya J.M., Territo A., Gallioli A., Aumatell J., Algaba F., Palou J., Breda A.. Indications and histology of 489 orchiectomies analyzed by patient age. Actas Urologicas Espanolas. 2023; 47(7)DOI:10.1016/j.acuro.2022.10.004. PMID:. IF:(Q/D).

Piana A., Prudhomme T., Boissier R., Hevia V., Alba S., Breda A., Territo A.. Comment on: “Outcomes of kidney transplantation from uncontrolled donors after circulatory death vs. expanded-criteria or standard-criteria donors after brain death at an Italian Academic Center: a prospective observational study”. Minerva Urology And Nephrology. 2023; 75(4)DOI:10.23736/S2724-6051.23.05431-9. PMID:37530664. IF:(Q/D).

Esperto F., Pietropaolo A., Emiliani E., de Coninck V., Tailly T., Keller E.X., Talso M., Tonyali S., Sener E.T., Zeeshan Hameed B.M., Tzelves L., Ventimiglia E., Juliebø-Jones P., Faiella E., Mykoniatis I., Tsaturyan A., Scarpa R.M.. Quality of life of patients with stone disease: timing, planning, strategies, and prevention of a systemic pathology. Minerva Urology And Nephrology. 2023; 75(4)DOI:10.23736/S2724-6051.23.05435-6. PMID:37314814. IF:4.900(Q1/2D).

Sanz Gómez I., Huguet J., Bravo A., Robalino J., Rodríguez Faba Ó., Territo Á., Gaya J.M., Palou J., Breda A.. Sequential Treatment With Bacillus Calmette-Güerin (BCG) and Mitomycin C Administered With Electromotive Drug Administration (EMDA) in Patients With High-Risk Nonmuscle Invasive Bladder Cancer After BCG Failure. Clinical Genitourinary Cancer. 2023; 21(4)DOI:10.1016/j.clgc.2023.03.002. PMID:37076337. IF:2.300(Q2/5D).

Grobet-Jeandin E., Lenfant L., Mir C., Giannarini G., Alcaraz A., Albersen M., Breda A., Briganti A., Rouprêt M., Seisen T., EAU Section of Oncological Urology (ESOU) Board. A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer. European Urology Oncology. 2023; 6(3)DOI:10.1016/j.euo.2023.02.008. PMID:36906510. IF:8.300(Q1/1D).

Tyson M.D., Morris D., Palou J., Rodriguez O., Mir M.C., Dickstein R.J., Guerrero-Ramos F., Scarpato K.R., Hafron J.M., Messing E.M., Cutie C.J., Maffeo J.C., Raybold B., Chau A., Stromberg K.A., Keegan K.A.. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients with Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study. JOURNAL OF UROLOGY. 2023; 209(5)DOI:10.1097/JU.0000000000003195. PMID:37026631. IF:6.400(Q1/1D).

Prudhomme T., Boissier R., Hevia V., Campi R., Pecoraro A., Breda A., Territo A.. Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: indications, timing and postoperative outcomes. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.04972-2. PMID:36094388. IF:4.900(Q1/2D).

Gallioli A., Basile G., Territo A., Verri P., Gaya J.M., Sanguedolce F., Aumatell J., Izquierdo P., Uleri A., Diana P., Huguet J., Algaba F., Palou J., Breda A.. The importance of second-look ureteroscopy implementation in the conservative management of upper tract urothelial carcinoma. WORLD JOURNAL OF UROLOGY. 2023; 41(10)DOI:10.1007/s00345-023-04577-8. PMID:37668716. IF:2.800(Q2/3D).

Huguet Pérez J., Rodríguez Faba O., Gaya Sopena J.M., Palou Redorta J., Breda A.. An aid to a better understanding of the definitions of bacillus Calmette Guerin failure provided by the European Urology Association. Actas Urologicas Espanolas. 2023; 47(7)DOI:10.1016/j.acuro.2023.01.003. PMID:. IF:(Q/D).

Emiliani E., Sanz-Gómez I., Somani B., Tailly T., Castellani D., Traxer O., Yuen-Chun Teoh J., Hall Chew B., Ong Lay Keat W., Chai C.A., Hamri Saeed B., Shrestha A., Soehabali B., Angerri O., Gauhar V.. Does gender influence retrograde intrarenal surgery (RIRS) outcomes? Data from the Flexible Ureteroscopy Outcomes Registry (FLEXOR). Actas Urologicas Espanolas. 2023; 47(9)DOI:10.1016/j.acuro.2023.04.002. PMID:. IF:(Q/D).

Territo A., Bajeot A.S., Mesnard B., Campi R., Pecoraro A., Hevia V., Piana A., Doumerc N., Breda A., Boissier R., Prudhomme T.. Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) – Young Academic Urologists (YAU) Kidney Transplant Working Group. Actas Urologicas Espanolas. 2023; 47(8)DOI:10.1016/j.acuro.2023.01.008. PMID:. IF:(Q/D).

van Straten C.G.J.I., Caris C., Grimm M.-O., Colombel M., Muilwijk T., Martínez-Piñeiro L., Babjuk M.M., Türkeri L.N., Palou J., Patel A., Bjartell A.S., Witjes W.P.J., van der Heijden A.G., Kiemeney L.A.L.M.. Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial. European Urology Open Science. 2023; 56DOI:10.1016/j.euros.2023.08.004. PMID:37822514. IF:3.200(Q1/2D).

Asimakopoulos A.D., Kochergin M., Colalillo G., Fahmy O., Hassan F., Renninger M., Gallioli A., Gavrilov P., Gakis G.. New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2023; 9(3)DOI:10.3233/BLC-230043. PMID:. IF:1.000(Q4/8D).

Tonyali S., Haberal H.B., Esperto F., Hamid Z., Tzelves L., Pietropaolo A., Emiliani E.. The Prime Time for Flexible Ureteroscopy for Large Renal Stones Is Coming: Is Percutaneous Nephrolithotomy No Longer Needed?. Urology Research And Practice. 2023; 49(5)DOI:10.5152/tud.2023.23142. PMID:. IF:(Q/D).

Pietropaolo A., Geraghty R., Griffin S., Skolarikos A., Seitz C., Bujons A., Sriprasad S., Subramonian S., Smith D., Contreras P., Bernardo N., Esperto F., Emiliani E., De Coninck V., Tailly T., Keller E.X., Talso M., Tonyali S., Sener E.T., Hameed B.M.Z., Tzelves L., Ventimiglia E., Juliebø-Jones P., Mykoniatis I., Tsaturyan A., Bres-Niewada E., Somani B.K.. Worldwide trends of practice and intervention in paediatric endourology: comparison of European versus Non-European responses. Central European Journal Of Urology. 2023; 76(3)DOI:10.5173/ceju.2023.79. PMID:38045778. IF:(Q/D).

Pérez-Fidalgo J.A., Ortega E., Ponce J., Redondo A., Sevilla I., Valverde C., Verdum, JI, de Alava E., Lopez, MG, Marquina G., Sebio A.. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Therapeutic Advances in Medical Oncology. 2023; 15DOI:10.1177/17588359231157645. PMID:37007636. IF:4.300(Q2/3D).

Bascuñana Ambrós H., de Miguel Benadiba C., Gil Fraguas L., Monguet Fierro J.M., Trejo Omeñaca Á.. Consensus measurement of innovation in physical medicine and rehabilitation. Rehabilitacion. 2023; 57(1)DOI:10.1016/j.rh.2022.01.002. PMID:35523615. IF:(Q/D).

Renom-Guiteras M., Najas-Sales V., Ramirez-Mirabal E., Nadal-Castells M.J., Pintor-Ojeda A., Bascuñana-Ambrós H.. Holistic semi-presential evaluation of oropharygeal dysphagia with the framework of International Classification of Functioning, Disability and Health: Optimizing evaluation to improve rehabilitation treatment. Rehabilitacion. 2023; 57(1)DOI:10.1016/j.rh.2022.03.001. PMID:35570031. IF:(Q/D).